In patients with DCM before and after PSM, factors including patient sex, age, NT-proBNP, WBC, PLT, neutrophil lymphocytes, IL6, CRP, NLR, PLR, and CLR could reliably predict DCM risk in patients. This evidence concerns the gene NPPB and familial dilated cardiomyopathy.